Skip to main content
Fig. 5 | Journal of Translational Medicine

Fig. 5

From: A novel approach for the co-delivery of 5-fluorouracil and everolimus for breast cancer combination therapy: stimuli-responsive chitosan hydrogel embedded with mesoporous silica nanoparticles

Fig. 5

In vitro efficacy of the nanosystem in 4T1 breast cancer cells. (a) Cell viability of 4T1 cells treated with various formulations, highlighting the cytotoxic effect of the nanocomposite-based co-delivery system; (b) Flow cytometry analysis showing the rate of apoptosis in treated 4T1 cells. *** P < 0.001

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us